Table 1.
Glycosylation sites and selected glycan compositions and sequences in this study.
| Site | Composition and Type | Sequence | Alternative Sequence(s) |
|---|---|---|---|
| N61 N122 N603 N709 N717 N801 N1074 |
HexNAc(2)Hex(5) High-Mannose |
 |
|
| N234 | HexNAc(2)Hex(8) High-Mannose |
 |
 |
| N657 | HexNAc(3)Hex(6) Hybrid |
 |
|
| N149 N331 N343 N616 N1134 |
HexNAc(4)Hex(3) Fuc(1) Complex |
 |
|
| N1158 | HexNAc(4)Hex(4) Complex |
 |
 |
| N10981 | HexNAc(4)Hex(4) Fuc(1)NeuAc(1) Complex |
 |
 |
| N1651 | HexNAc(4)Hex(5) Fuc(3)NeuAc(1) Complex |
 |
 |
| N282 | HexNAc(5)Hex(3) Fuc(1) Complex |
 |
|
| N172 | HexNAc(5)Hex(4) Fuc(1) Complex |
 |
|
| N1173 | HexNAc(6)Hex(3) Fuc(1) Complex |
 |
|
| N743 | HexNAc(6)Hex(4) Fuc(1)NeuAc(1) Complex |
 |
|
| N11944 | HexNAc(6)Hex(5) Fuc(1) NeuAc(1) Complex |
 |
|
| T323 | O-glycan |  |
 |
1
Neu5Ac can also be α2–3 or α2–6 linked to Gal.
2
The non-reducing terminal Gal can also be β1–4 linked to any of three GlcNAc.
3
The non-reducing terminal Neu5Acα2–3Gal or Neu5Acα2–6Gal can also be β1–4 linked to any of four GlcNAc.
4
Gal can also be β1–4 linked to any two of four GlcNAc, and Neu5Ac can be α2–3 or α2–6 linked to either of two Gal.